52 Week Range
As of on the Tel Aviv Stock Exchange ∙ Minimum 15 minute delay
3M AVG Volume
52 Week High
52 Week Low
Shares Out (MIL)
Market Cap (MIL)
Dividend (Yield %)
Intercure's Canndoc Entered Into Strategic Partnership Agreement With Super-Pharm
Intercure Says Unit Canndoc Entered Strategic Distribution Agreement With Teva Pharmaceuticals Unit
Intercure Ltd Announces Resignation of Chief Executive Officer, Mr. Erez Gavish; Appoints Mr. Ronen Twito as Replacement-Complete Story
InterCure Ltd is an Israel-based medical device company. It is engaged in the production and sale of RESPeRATE, a Food and Drug Administration approved, non-drug, non-invasive hypertension treatment device. The Company’s patented device-guided breathing platform is used by RESPeRATE, and it enables a systematic reduction in sympathetic outflow of the autonomous nervous system, one of the key underlining causes for cardiovascular disease, insomnia and multiple other conditions. The Company operates a marketing office in London and outsourced call centers and warehouses in the United States, the United Kingdom, Germany and Canada.
Medical Equipment & Supplies
Medinat HaYehudim 85
Chairman of the Board
Chief Executive Officer, Director
Vice President - Finance
Price To Earnings (TTM)
Price To Sales (TTM)
Price To Book (MRQ)
Price To Cash Flow (TTM)
Total Debt To Equity (MRQ)
LT Debt To Equity (MRQ)
Return on Investment (TTM)
Return on Equity (TTM)
* INTERCURE LTD - ENTERED INTO STRATEGIC PARTNERSHIP AGREEMENT WITH SUPER-PHARM
Canndoc, an Israeli producer of medical grade cannabis, on Sunday received a shipment of 250 kilos of dried whole cannabis flowers that it says will help alleviate a shortage in Israel.
Israel's InterCure Ltd said on Thursday its subsidiary Canndoc has signed a strategic cooperation agreement with Tilray Inc for the import and export of medical cannabis.
Israel will likely allow exports of medical cannabis by the end of the year, a top lawmaker said on Thursday, a move that would boost state coffers and slow the growing number of firms establishing farms abroad.
Israel's InterCure <INCR.TA>, which recently entered the medical cannabis market, plans to list on Nasdaq by mid-2019, its controlling shareholder, Alex Rabinovitch, said on Thursday.
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.